Myrtelle Launches Commercial Manufacturing First-in-Class Gene Therapy
Myrtelle Launches Commercial-Stage Manufacturing of First-in-Class Gene Therapy for Canavan Disease.
Article Date
July 8, 2025
This article is featured on another website.
Go to article
September 11, 2026
Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials
Part 4 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
September 11, 2026
Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials
Part 4 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…